Search & Analyze
Popular Searches
Torrent Pharmaceuticals Ltd.
Healthcare₹4,959.800.65%
24 Jul, 4:01 PM
CMP₹4,959.80
Mkt Cap₹1.93L Cr
P/E89.07
P/B22.91
ROE26.76%
52W High₹5,084.85
52W Low₹3,480.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
89.07
P/B Ratio
22.91
EV/EBITDA
46.21
Price/Sales
13.78
Dividend Yield (%)
0.75
EPS (TTM ₹)
56.88
Book Value (₹)
221.09
ROE (%)
26.76
ROCE (%)
19.27
ROA (%)
7.37
EBITDA Margin (%)
22.22
Net Profit Margin (%)
10.86
Debt/Equity
1.76
Current Ratio
1.13
Interest Coverage
8.46
Asset Turnover
0.68
Working Capital/Sales
18.77
Core EBITDA Growth (%)
19.25
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 8508.04 | 9620.15 | 10727.84 | 11516.09 | 13979.73 |
| Net Sales | 8508.04 | 9620.15 | 10727.84 | 11516.09 | 13979.73 |
| Total Income | 8704.6 | 9683.37 | 10789.81 | 11556 | 14071.44 |
| Total Expenditure | 6076.77 | 6796.18 | 7364.25 | 7811.74 | 9606.56 |
| Operating Profit | 2627.83 | 2887.19 | 3425.56 | 3744.26 | 4464.88 |
| Depreciation | 662.16 | 706.59 | 808.27 | 794.93 | 1118.87 |
| Exceptional Items | -484.7 | — | 88.38 | -24.21 | -88.75 |
| Profit Before Tax | 1225.91 | 1847.16 | 2352.11 | 2672.81 | 2872.19 |
| Tax | 448.73 | 601.93 | 695.73 | 761.56 | 734.01 |
| Profit After Tax (PAT) | 777.18 | 1245.23 | 1656.38 | 1911.25 | 2138.18 |
| EPS (₹) | 22.96 | 36.79 | 48.94 | 56.47 | 63.92 |
| Dividend Payout % | 960 | 440 | 560 | 640 | 760 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 84.62 | 169.23 | 169.23 | 169.23 | 169.23 |
| Reserves | 5868.33 | 6028.84 | 6686.92 | 7421.46 | 8219.2 |
| Shareholders Funds | 5952.95 | 6198.07 | 6856.15 | 7590.69 | 8388.43 |
| Total Debt | 4018.1 | 5297.3 | 3937.42 | 3026.09 | 14798.24 |
| Total Liabilities | 12606.19 | 14468.18 | 14505.45 | 14395.59 | 43613.69 |
| Total Assets | 12606.19 | 14468.18 | 14505.45 | 14395.59 | 43613.69 |
| Book Value / Share | 351.746 | 183.1256 | 202.569 | 224.2714 | 247.8411 |
| Assets | 12606.19 | 14468.18 | 14505.45 | 14395.59 | 43613.69 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 1802.99 | 2368.13 | 3266.08 | 2585.11 | 3022.71 |
| Investing Activities | -196.63 | -2415.31 | -167.9 | -540.05 | -12712.41 |
| Financing Activities | -1781.05 | 77.36 | -2779.64 | -2297.99 | 10150.6 |
| Net Cash Flow | -174.69 | 30.18 | 318.54 | -252.93 | 460.9 |
TORNTPHARM
₹4,959.80
-0.65%